Benchmarking of QSAR models for blood-brain barrier permeation

被引:67
|
作者
Konovalov, Dmitry A. [1 ]
Coomans, Danny
Deconinck, Eric
Vander Heyden, Yvan
机构
[1] James Cook Univ N Queensland, Sch Math Phys & Informat Technol, Townsville, Qld, Australia
[2] Vrije Univ Brussels, Inst Pharmaceut, Dept Analyt Chem & Pharmaceut Technol, Brussels, Belgium
关键词
D O I
10.1021/ci700100f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using the largest available database of 328 blood-brain distribution (logBB) values, a quantitative benchmark was proposed to allow for a consistent comparison of the predictive accuracy of current and future logBB/quantitative structure-activity relationship (-QSAR) models. The usefulness of the benchmark was illustrated by comparing the global and k-nearest neighbors (kNN) multiple-linear regression (MLR) models based on the linear free-energy relationship (LFER) descriptors, and one non-LFER-based MLR model. The leave-one-out (LOO) and leave-group-out Monte Carlo (MC) cross-validation results (q(2) = 0.766, qms = 0.290, and qms(mc) = 0.311) indicated that the LFER-based kNN-MLR model was currently one of the most accurate predictive logBB-QSAR models. The LOO, MC, and kNN-MLR methods have been implemented in the QSAR-BENCH program, which is freely available from www.dmitrykonovalov.org for academic use.
引用
收藏
页码:1648 / 1656
页数:9
相关论文
共 50 条
  • [31] Reproducibility in biological models of the blood-brain barrier
    Hudecz, Diana
    Rocks, Louise
    Fitzpatrick, Laurence W.
    Herda, Luciana-Maria
    Dawson, Kenneth A.
    EUROPEAN JOURNAL OF NANOMEDICINE, 2014, 6 (03) : 185 - 193
  • [32] Permeability of in vitro Blood-Brain Barrier Models
    Li, Guanglei
    Simon, Melissa J.
    Cancel, Limary
    Shi, Zhong-Dong
    Ji, Xinying
    Tarbell, John M.
    Morrison, Barclay, III
    Fu, Bingmei M.
    2010 IEEE 36TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 2010,
  • [33] In vitro experimental models for the blood-brain barrier
    Li, AP
    DRUG DISCOVERY TODAY, 2004, 9 (05) : 204 - 205
  • [34] Assays to Predict Drug Permeation Across the Blood-Brain Barrier, and Distribution to Brain
    Abbott, N. J.
    Dolman, D. E. M.
    Patabendige, A. K.
    CURRENT DRUG METABOLISM, 2008, 9 (09) : 901 - 910
  • [35] QSAR modeling of the Blood-Brain Barrier permeability for diverse organic compounds
    Zhang, Liying
    Zhu, Hao
    Oprea, Tudor I.
    Golbraikh, Alexander
    Tropsha, Alexander
    PHARMACEUTICAL RESEARCH, 2008, 25 (08) : 1902 - 1914
  • [36] Next-generation in vitro blood-brain barrier models: benchmarking and improving model accuracy COMMENT
    Linville, Raleigh M.
    Searson, Peter C.
    FLUIDS AND BARRIERS OF THE CNS, 2021, 18 (01)
  • [37] Blood-brain barrier permeation: Molecular parameters governing passive diffusion
    Fischer, H
    Gottschlich, R
    Seelig, A
    JOURNAL OF MEMBRANE BIOLOGY, 1998, 165 (03): : 201 - 211
  • [38] Transporter-mediated permeation of drugs across the blood-brain barrier
    Tamai, I
    Tsuji, A
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 89 (11) : 1371 - 1388
  • [39] Adenosine permeation of a dynamic in vitro blood-brain barrier inhibited by dipyridamole
    Sinclair, CJD
    Krizanac-Bengez, L
    Stanness, KA
    Janigro, D
    Parkinson, FE
    BRAIN RESEARCH, 2001, 898 (01) : 122 - 125
  • [40] Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
    H. Fischer
    R. Gottschlich
    A. Seelig
    The Journal of Membrane Biology, 1998, 165 : 201 - 211